This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Asai, N.
Right arrow Articles by Takahashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Asai, N.
Right arrow Articles by Takahashi, M.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 03 1995, 1613-1619, Vol 15, No. 3
Copyright © 1995, American Society for Microbiology

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations

N Asai, T Iwashita, M Matsuyama and M Takahashi
Department of Pathology, Nagoya University School of Medicine, Japan.

Transforming activity of the c-ret proto-oncogene with multiple endocrine neoplasia (MEN) 2A mutations was investigated by transfection of NIH 3T3 cells. Mutant c-ret genes driven by the simian virus 40 or cytomegalovirus promoter induced transformation with high efficiencies. The 170-kDa Ret protein present on the cell surface of transformed cells was highly phosphorylated on tyrosine and formed disulfide-linked homodimers. This result indicated that MEN 2A mutations induced ligand- independent dimerization of the c-Ret protein on the cell surface, leading to activation of its intrinsic tyrosine kinase. In addition to the MEN 2A mutations, we further introduced a mutation (lysine for asparaginic acid at codon 300 [D300K]) in a putative Ca(2+)-binding site of the cadherin-like domain. When c-ret cDNA with both MEN 2A and D300K mutations was transfected into NIH 3T3 cells, transforming activity drastically decreased. Western blot (immunoblot) analysis revealed that very little of the 170-kDa Ret protein with the D300K mutation was expressed in transfectants while expression of the 150-kDa Ret protein retained in the endoplasmic reticulum was not affected. This result also demonstrated that transport of the Ret protein to the plasma membrane is required for its transforming activity.


This article has been cited by other articles:

  • van Veelen, W., van Gasteren, C. J.R., Acton, D. S., Franklin, D. S., Berger, R., Lips, C. J.M., Hoppener, J. W.M. (2008). Synergistic Effect of Oncogenic RET and Loss of p18 on Medullary Thyroid Carcinoma Development. Cancer Res. 68: 1329-1337 [Abstract] [Full Text]  
  • de Groot, J. W. B., Links, T. P., Plukker, J. T. M., Lips, C. J. M., Hofstra, R. M. W. (2006). RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors. Endocr. Rev. 27: 535-560 [Abstract] [Full Text]  
  • Cranston, A., Carniti, C., Martin, S., Mondellini, P., Hooks, Y., Leyland, J., Hodgson, S., Clarke, S., Pierotti, M., Ponder, B. A. J., Bongarzone, I. (2006). A Novel Activating Mutation in the RET Tyrosine Kinase Domain Mediates Neoplastic Transformation. Mol. Endocrinol. 20: 1633-1643 [Abstract] [Full Text]  
  • Carniti, C., Belluco, S., Riccardi, E., Cranston, A. N., Mondellini, P., Ponder, B. A.J., Scanziani, E., Pierotti, M. A., Bongarzone, I. (2006). The RetC620R Mutation Affects Renal and Enteric Development in a Mouse Model of Hirschsprung's Disease. Am. J. Pathol. 168: 1262-1275 [Abstract] [Full Text]  
  • Strock, C. J., Park, J.-I., Rosen, D. M., Ruggeri, B., Denmeade, S. R., Ball, D. W., Nelkin, B. D. (2006). Activity of Irinotecan and the Tyrosine Kinase Inhibitor CEP-751 in Medullary Thyroid Cancer. J. Clin. Endocrinol. Metab. 91: 79-84 [Abstract] [Full Text]  
  • Freche, B., Guillaumot, P., Charmetant, J., Pelletier, L., Luquain, C., Christiansen, D., Billaud, M., Manie, S. N. (2005). Inducible Dimerization of RET Reveals a Specific AKT Deregulation in Oncogenic Signaling. J. Biol. Chem. 280: 36584-36591 [Abstract] [Full Text]  
  • Jung, H. S., Kim, D. W., Jo, Y. S., Chung, H. K., Song, J. H., Park, J. S., Park, K. C., Park, S. H., Hwang, J. H., Jo, K.-W., Shong, M. (2005). Regulation of Protein Kinase B Tyrosine Phosphorylation by Thyroid-Specific Oncogenic RET/PTC Kinases. Mol. Endocrinol. 19: 2748-2759 [Abstract] [Full Text]  
  • Read, R. D., Goodfellow, P. J., Mardis, E. R., Novak, N., Armstrong, J. R., Cagan, R. L. (2005). A Drosophila Model of Multiple Endocrine Neoplasia Type 2. Genetics 171: 1057-1081 [Abstract] [Full Text]  
  • Hwang, E. S., Kim, D. W., Hwang, J. H., Jung, H. S., Suh, J. M., Park, Y. J., Chung, H. K., Song, J. H., Park, K. C., Park, S. H., Yun, H.-J., Kim, J. M., Shong, M. (2004). Regulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT1-Dependent Genes by RET/PTC (Rearranged in Transformation/Papillary Thyroid Carcinoma) Oncogenic Tyrosine Kinases. Mol. Endocrinol. 18: 2672-2684 [Abstract] [Full Text]  
  • Drosten, M., Hilken, G., Bockmann, M., Rodicker, F., Mise, N., Cranston, A. N., Dahmen, U., Ponder, B. A. J., Putzer, B. M. (2004). Role of MEN2A-Derived RET in Maintenance and Proliferation of Medullary Thyroid Carcinoma. JNCI J Natl Cancer Inst 96: 1231-1239 [Abstract] [Full Text]  
  • Arighi, E., Popsueva, A., Degl'Innocenti, D., Borrello, M. G., Carniti, C., Perala, N. M., Pierotti, M. A., Sariola, H. (2004). Biological Effects of the Dual Phenotypic Janus Mutation of ret Cosegregating with Both Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease. Mol. Endocrinol. 18: 1004-1017 [Abstract] [Full Text]  
  • Glaser, R. L., Jabs, E. W. (2004). Dear Old Dad. Sci Aging Knowl Environ 2004: re1-re1 [Abstract] [Full Text]  
  • Fukuda, N., Ichihara, M., Morinaga, T., Kawai, K., Hayashi, H., Murakumo, Y., Matsuo, S., Takahashi, M. (2003). Identification of a Novel Glial Cell Line-derived Neurotrophic Factor-inducible Gene Required for Renal Branching Morphogenesis. J. Biol. Chem. 278: 50386-50392 [Abstract] [Full Text]  
  • Strock, C. J., Park, J.-I., Rosen, M., Dionne, C., Ruggeri, B., Jones-Bolin, S., Denmeade, S. R., Ball, D. W., Nelkin, B. D. (2003). CEP-701 and CEP-751 Inhibit Constitutively Activated RET Tyrosine Kinase Activity and Block Medullary Thyroid Carcinoma Cell Growth. Cancer Res. 63: 5559-5563 [Abstract] [Full Text]  
  • Kjaer, S., Ibanez, C. F. (2003). Intrinsic susceptibility to misfolding of a hot-spot for Hirschsprung disease mutations in the ectodomain of RET. Hum Mol Genet 12: 2133-2144 [Abstract] [Full Text]  
  • Carniti, C., Perego, C., Mondellini, P., Pierotti, M. A., Bongarzone, I. (2003). PP1 Inhibitor Induces Degradation of RETMEN2A and RETMEN2B Oncoproteins through Proteosomal Targeting. Cancer Res. 63: 2234-2243 [Abstract] [Full Text]  
  • Yip, L., Cote, G. J., Shapiro, S. E., Ayers, G. D., Herzog, C. E., Sellin, R. V., Sherman, S. I., Gagel, R. F., Lee, J. E., Evans, D. B. (2003). Multiple Endocrine Neoplasia Type 2: Evaluation of the Genotype-Phenotype Relationship. Arch Surg 138: 409-416 [Abstract] [Full Text]  
  • Murakami, H., Yamamura, Y., Shimono, Y., Kawai, K., Kurokawa, K., Takahashi, M. (2002). Role of Dok1 in Cell Signaling Mediated by RET Tyrosine Kinase. J. Biol. Chem. 277: 32781-32790 [Abstract] [Full Text]  
  • Okazaki, N., Takahashi, N., Kojima, S.-i., Masuho, Y., Koga, H. (2002). Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis 23: 1139-1148 [Abstract] [Full Text]  
  • Watanabe, T., Ichihara, M., Hashimoto, M., Shimono, K., Shimoyama, Y., Nagasaka, T., Murakumo, Y., Murakami, H., Sugiura, H., Iwata, H., Ishiguro, N., Takahashi, M. (2002). Characterization of Gene Expression Induced by RET with MEN2A or MEN2B Mutation. Am. J. Pathol. 161: 249-256 [Abstract] [Full Text]  
  • Kato, M., Takeda, K., Kawamoto, Y., Iwashita, T., Akhand, A. A., Senga, T., Yamamoto, M., Sobue, G., Hamaguchi, M., Takahashi, M., Nakashima, I. (2002). Repair by Src Kinase of Function-impaired RET with Multiple Endocrine Neoplasia Type 2A Mutation with Substitutions of Tyrosines in the COOH-Terminal Kinase Domain for Phenylalanine. Cancer Res. 62: 2414-2422 [Abstract] [Full Text]  
  • Mograbi, B., Bocciardi, R., Bourget, I., Juhel, T., Farahi-Far, D., Romeo, G., Ceccherini, I., Rossi, B. (2001). The Sensitivity of Activated Cys Ret Mutants to Glial Cell Line-Derived Neurotrophic Factor Is Mandatory To Rescue Neuroectodermic Cells from Apoptosis. Mol. Cell. Biol. 21: 6719-6730 [Abstract] [Full Text]  
  • Ludwig, L., Kessler, H., Wagner, M., Hoang-Vu, C., Dralle, H., Adler, G., Bohm, B. O., Schmid, R. M. (2001). Nuclear Factor-{{kappa}}B Is Constitutively Active in C-Cell Carcinoma and Required for RET-induced Transformation. Cancer Res. 61: 4526-4535 [Abstract] [Full Text]  
  • Salvatore, D., Melillo, R. M., Monaco, C., Visconti, R., Fenzi, G., Vecchio, G., Fusco, A., Santoro, M. (2001). Increased in Vivo Phosphorylation of Ret Tyrosine 1062 Is a Potential Pathogenetic Mechanism of Multiple Endocrine Neoplasia Type 2B. Cancer Res. 61: 1426-1431 [Abstract] [Full Text]  
  • Hansford, J. R, Mulligan, L. M (2000). Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J. Med. Genet. 37: 817-827 [Abstract] [Full Text]  
  • Salvatore, D., Barone, M. V., Salvatore, G., Melillo, R. M., Chiappetta, G., Mineo, A., Fenzi, G., Vecchio, G., Fusco, A., Santoro, M. (2000). Tyrosines 1015 and 1062 Are in VivoAutophosphorylation Sites in Ret and Ret-Derived Oncoproteins. J. Clin. Endocrinol. Metab. 85: 3898-3907 [Abstract] [Full Text]  
  • Kawai, K., Iwashita, T., Murakami, H., Hiraiwa, N., Yoshiki, A., Kusakabe, M., Ono, K., Iida, K.-i., Nakayama, A., Takahashi, M. (2000). Tissue-specific Carcinogenesis in Transgenic Mice Expressing the RET Proto-Oncogene with a Multiple Endocrine Neoplasia Type 2A Mutation. Cancer Res. 60: 5254-5260 [Abstract] [Full Text]  
  • Colucci-D'Amato, G. L., D'Alessio, A., Califano, D., Cali, G., Rizzo, C., Nitsch, L., Santelli, G., de Franciscis, V. (2000). Abrogation of Nerve Growth Factor-induced Terminal Differentiation by ret Oncogene Involves Perturbation of Nuclear Translocation of ERK. J. Biol. Chem. 275: 19306-19314 [Abstract] [Full Text]  
  • Le Hir, H., Colucci-D’Amato, L. G., Charlet-Berguerand, N., Plouin, P.-F., Bertagna, X., Vittorio de Franciscis, , Thermes, C. (2000). High Levels of Tyrosine Phosphorylated Proto-Ret in Sporadic Pheochromocytomas. Cancer Res. 60: 1365-1370 [Abstract] [Full Text]  
  • Segouffin-Cariou, C., Billaud, M. (2000). Transforming Ability of MEN2A-RET Requires Activation of the Phosphatidylinositol 3-Kinase/AKT Signaling Pathway. J. Biol. Chem. 275: 3568-3576 [Abstract] [Full Text]  
  • Kato, M., Iwashita, T., Takeda, K., Akhand, A. A., Liu, W., Yoshihara, M., Asai, N., Suzuki, H., Takahashi, M., Nakashima, I. (2000). Ultraviolet Light Induces Redox Reaction-mediated Dimerization and Superactivation of Oncogenic Ret Tyrosine Kinases. Mol. Biol. Cell 11: 93-101 [Abstract] [Full Text]  
  • Tessitore, A., Sinisi, A. A., Pasquali, D., Cardone, M., Vitale, D., Bellastella, A., Colantuoni, V. (1999). A Novel Case of Multiple Endocrine Neoplasia Type 2A Associated with Two de Novo Mutations of the RETProtooncogene. J. Clin. Endocrinol. Metab. 84: 3522-3527 [Abstract] [Full Text]  
  • Ishiguro, Y., Iwashita, T., Murakami, H., Asai, N., Iida, K.-i., Goto, H., Hayakawa, T., Takahashi, M. (1999). The Role of Amino Acids Surrounding Tyrosine 1062 in Ret in Specific Binding of the Shc Phosphotyrosine-Binding Domain. Endocrinology 140: 3992-3998 [Abstract] [Full Text]  
  • Pigny, P., Bauters, C., Wemeau, J.-L., Lecomte Houcke, M., Crepin, M., Caron, P., Giraud, S., Calender, A., Buisine, M.-P., Kerckaert, J.-P., Porchet, N. (1999). A Novel 9-Base Pair Duplication in RET Exon 8 in Familial Medullary Thyroid Carcinoma. J. Clin. Endocrinol. Metab. 84: 1700-1704 [Abstract] [Full Text]  
  • Labrecque, J., Mc Nicoll, N., Marquis, M., De Lean, A. (1999). A Disulfide-bridged Mutant of Natriuretic Peptide Receptor-A Displays Constitutive Activity. ROLE OF RECEPTOR DIMERIZATION IN SIGNAL TRANSDUCTION. J. Biol. Chem. 274: 9752-9759 [Abstract] [Full Text]  
  • Srinivas, S, Wu, Z, Chen, C., D'Agati, V, Costantini, F (1999). Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development. Development 126: 1375-1386 [Abstract]  
  • Bardelli, A., Longati, P., Gramaglia, D., Basilico, C., Tamagnone, L., Giordano, S., Ballinari, D., Michieli, P., Comoglio, P. M. (1998). Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth. Proc. Natl. Acad. Sci. USA 95: 14379-14383 [Abstract] [Full Text]  
  • Carlomagno, F., Melillo, R. M., Visconti, R., Salvatore, G., De Vita, G., Lupoli, G., Yu, Y., Jing, S., Vecchio, G., Fusco, A., Santoro, M. (1998). Glial Cell Line-Derived Neurotrophic Factor Differentially Stimulates Ret Mutants Associated with the Multiple Endocrine Neoplasia Type 2 Syndromes and Hirschsprung's Disease. Endocrinology 139: 3613-3619 [Abstract] [Full Text]  
  • Cosma, M. P., Cardone, M., Carlomagno, F., Colantuoni, V. (1998). Mutations in the Extracellular Domain Cause RET Loss of Function by a Dominant Negative Mechanism. Mol. Cell. Biol. 18: 3321-3329 [Abstract] [Full Text]  
  • van Weering, D. H. J., Moen, T. C., Braakman, I., Baas, P. D., Bos, J. L. (1998). Expression of the Receptor Tyrosine Kinase Ret on the Plasma Membrane Is Dependent on Calcium. J. Biol. Chem. 273: 12077-12081 [Abstract] [Full Text]  
  • Sakai, T., Wakizaka, A., Matsuda, H., Nirasawa, Y., Itoh, Y. (1998). Point Mutation in Exon 12 of the Receptor Tyrosine Kinase Proto-oncogene RET in Ondine-Hirschsprung Syndrome. Pediatrics 101: 924-925 [Abstract] [Full Text]  
  • Xing, S., Furminger, T. L., Tong, Q., Jhiang, S. M. (1998). Signal Transduction Pathways Activated by RET Oncoproteins in PC12 Pheochromocytoma Cells. J. Biol. Chem. 273: 4909-4914 [Abstract] [Full Text]  
  • Schuffenecker, I., Virally-Monod, M., Brohet, R., Goldgar, D., Conte-Devolx, B., Leclerc, L., Chabre, O., Boneu, A., Caron, J., Houdent, C., Modigliani, E., Rohmer, V., Schlumberger, M., Eng, C., Guillausseau, P. J., Lenoir, G. M. (1998). Risk and Penetrance of Primary Hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A Families with Mutations at Codon 634 of the RET Proto-Oncogene. J. Clin. Endocrinol. Metab. 83: 487-491 [Abstract] [Full Text]  
  • Michiels, F.-M., Chappuis, S., Caillou, B., Pasini, A., Talbot, M., Monier, R., Lenoir, G. M., Feunteun, J., Billaud, M. (1997). Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Proc. Natl. Acad. Sci. USA 94: 3330-3335 [Abstract] [Full Text]  
  • Pandit, SunilD., O'Hare, T., Donis-Keller, H., Pike, LindaJ. (1997). Functional Characterization of an Epidermal Growth Factor Receptor/RET Chimera. J. Biol. Chem. 272: 2199-2206 [Abstract] [Full Text]  
  • van Weering, D. H.J., Bos, J. L. (1997). Glial Cell Line-derived Neurotrophic Factor Induces Ret-mediated Lamellipodia Formation. J. Biol. Chem. 272: 249-254 [Abstract] [Full Text]  
  • Rizzo, C., Califano, D., Colucci-D'Amato, G. L., De Vita, G., D'Alessio, A., Dathan, N. A., Fusco, A., Monaco, C., Santelli, G., Vecchio, G., Santoro, M., de Franciscis, V. (1996). Ligand Stimulation of a Ret Chimeric Receptor Carrying the Activating Mutation Responsible for the Multiple Endocrine Neoplasia Type 2B. J. Biol. Chem. 271: 29497-29501 [Abstract] [Full Text]  
  • Worby, C. A., Vega, Q. C., Zhao, Y., Chao, H. H.-J., Seasholtz, A. F., Dixon, J. E. (1996). Glial Cell Line-derived Neurotrophic Factor Signals through the RET Receptor and Activates Mitogen-activated Protein Kinase. J. Biol. Chem. 271: 23619-23622 [Abstract] [Full Text]  
  • Eng, C. (1996). The RET Proto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease. NEJM 335: 943-951 [Full Text]  
  • Asai, N., Murakami, H., Iwashita, T., Takahashi, M. (1996). A Mutation at Tyrosine 1062in MEN2A-Ret and MEN2B-Ret Impairs Their Transforming Activity and Association with Shc Adaptor Proteins. J. Biol. Chem. 271: 17644-17649 [Abstract] [Full Text]  
  • Pandey, A., Liu, X., Dixon, J. E., Di Fiore, P. P., Dixit, V. M. (1996). Direct Association between the Ret Receptor Tyrosine Kinase and the Src Homology 2-containing Adapter Protein Grb7. J. Biol. Chem. 271: 10607-10610 [Abstract] [Full Text]  
  • Pandit, S. D., Donis-Keller, H., Iwamoto, T., Tomich, J. M., Pike, L. J. (1996). The Multiple Endocrine Neoplasia Type 2B Point Mutation Alters Long-term Regulation and Enhances the Transforming Capacity of the Epidermal Growth Factor Receptor. J. Biol. Chem. 271: 5850-5858 [Abstract] [Full Text]  
  • Pandey, A., Duan, H., Di Fiore, P. P., Dixit, V. M. (1995). The Ret Receptor Protein Tyrosine Kinase Associates with the SH2-containing Adapter Protein Grb10. J. Biol. Chem. 270: 21461-21463 [Abstract] [Full Text]  
  • McManus, M. J., Boerner, J. L., Danielsen, A. J., Wang, Z., Matsumura, F., Maihle, N. J. (2000). An Oncogenic Epidermal Growth Factor Receptor Signals via a p21-activated Kinase-Caldesmon-Myosin Phosphotyrosine Complex. J. Biol. Chem. 275: 35328-35334 [Abstract] [Full Text]  
  • Gomez, A., Wellbrock, C., Gutbrod, H., Dimitrijevic, N., Schartl, M. (2001). Ligand-independent Dimerization and Activation of the Oncogenic Xmrk Receptor by Two Mutations in the Extracellular Domain. J. Biol. Chem. 276: 3333-3340 [Abstract] [Full Text]  
  • Qiao, S., Iwashita, T., Furukawa, T., Yamamoto, M., Sobue, G., Takahashi, M. (2001). Differential Effects of Leukocyte Common Antigen-related Protein on Biochemical and Biological Activities of RET-MEN2A and RET-MEN2B Mutant Proteins. J. Biol. Chem. 276: 9460-9467 [Abstract] [Full Text]  
  • Coulpier, M., Anders, J., Ibanez, C. F. (2002). Coordinated Activation of Autophosphorylation Sites in the RET Receptor Tyrosine Kinase. IMPORTANCE OF TYROSINE 1062 FOR GDNF MEDIATED NEURONAL DIFFERENTIATION AND SURVIVAL. J. Biol. Chem. 277: 1991-1999 [Abstract] [Full Text]  
  • Califano, D., Rizzo, C., D'Alessio, A., Colucci-D'Amato, G. L., Cali, G., Bartoli, P. C., Santelli, G., Vecchio, G., de Franciscis, V. (2000). Signaling through Ras Is Essential for ret Oncogene-induced Cell Differentiation in PC12 Cells. J. Biol. Chem. 275: 19297-19305 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»